N'-Formylkynurenine
A chemical compound related to tryptophan metabolism
| Chemical Compound | |
|---|---|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider ID | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| Properties | |
| Chemical Formula | |
| Molar Mass | |
| Appearance | |
| Density | |
| Melting Point | |
| Boiling Point | |
| Hazards | |
| GHS Pictograms | [[File:|50px]] |
| GHS Signal Word | |
| GHS Hazard Statements | |
| NFPA 704 | [[File:|50px]] |
| References | |
N'-Formylkynurenine is an intermediate in the metabolism of the essential amino acid tryptophan. It is formed by the action of the enzyme indoleamine 2,3-dioxygenase (IDO) or tryptophan 2,3-dioxygenase (TDO) on tryptophan, leading to the production of kynurenine pathway metabolites.
Biological Role[edit | edit source]
N'-Formylkynurenine plays a crucial role in the kynurenine pathway, which is the primary route of tryptophan catabolism in mammals. This pathway is involved in the production of several bioactive metabolites, including kynurenic acid, quinolinic acid, and nicotinamide adenine dinucleotide (NAD+).
Enzymatic Conversion[edit | edit source]
The conversion of tryptophan to N'-formylkynurenine is catalyzed by the enzymes IDO and TDO. These enzymes incorporate molecular oxygen into the indole ring of tryptophan, resulting in the formation of N'-formylkynurenine. This reaction is the first and rate-limiting step in the kynurenine pathway.
Clinical Significance[edit | edit source]
Alterations in the kynurenine pathway, including changes in the levels of N'-formylkynurenine, have been associated with various diseases, such as neurodegenerative disorders, cancer, and immune system dysfunctions. The pathway's metabolites can influence neurotransmission, immune response, and cellular energy metabolism.
Research and Applications[edit | edit source]
Research into N'-formylkynurenine and the kynurenine pathway is ongoing, with potential applications in developing therapeutic strategies for diseases linked to tryptophan metabolism. Modulating the activity of IDO and TDO, and thereby altering the levels of N'-formylkynurenine and other kynurenine pathway metabolites, is a promising area of study.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
